Larvol Delta - Artax-Biopharma-presents-Phase-2a-results-for-oral-Nck-modulator-AX158-in-latebreaking-session-at-the-Society-for-Investigative-Dermatology-2025-Annual-Meeting

AX-158 - Artax Biopharma

https://www.globenewswire.com/news-release/2025/05/09/3078045/0/en/Artax-Biopharma-presents-Phase-2a-results-for-oral-Nck-modulator-AX-158-in-late-breaking-session-at-the-Society-for-Investigative-Dermatology-2025-Annual-Meeting.html

May 9, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next